Comparison of Analgesic Efficacy of ESP Block and Caudal Block in Patients Undergoing Hypospadias Surgery
Post Operative Pain, Hypospadias
About this trial
This is an interventional treatment trial for Post Operative Pain focused on measuring sacral erector spinae plane block, caudal block, hypospadias, pediatric surgery
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiology (ASA) I-II group 6 months to 7 years old Paediatric age group patients who will undergo hypospadias surgery under general anesthesia Exclusion Criteria: ASA III - IV patient group Patients who were operated on urgently Patient relatives who did not give consent Presence of local anesthetic allergy Presence of infection in the area to be blocked Presence of coagulation disorder Severe organ failure Pre-existing neurological deficit Mental Retardation Anatomical Deformity
Sites / Locations
- Sisli Hamidiye Etfal Research and Training HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
GROUP ESP
GROUP C
Before the operation, under general anesthesia, group ESP (n=30) patients will be blocked with the sacral ESP block method. By giving the lateral decubitus position, the linear ultrasound probe will be placed in the sterilized area longitudinally on the midline of the sacrum. The erector spinae muscle and the sacral medial crest will be visualized. The 22 gauge, 50 mm needle will be advanced in the direction from cranial to caudal to reach the sacral crest. 0.25% bupivacaine from a dose of 1 mL kg-1 will be aspirated and injected every 2 mL under the erector spina muscle at the level of the median sacral crest at the level of the 4th sacral vertebra. (A test dose will be administered with 1 mL of saline.)
Group C (n=30) patients to whom caudal block will be applied will be placed in the lateral decubitus position and the linear ultrasound probe will be placed longitudinally in the sterilized area on the midline of the sacrum. A 2.5 cm 22 gauge needle will be inserted over the back skin of the sacral hiatus (located distal to the sacrum and formed by the two sacral cornua on its lateral edges) at a 90° position. The sacrococcygeal ligament will be crossed, the needle will be oriented approximately 25° and advanced approximately 2 to 3 mm to reach the sacral canal. After entering the sacral hiatus and confirming the location with negative aspiration method, 1 mL kg-1 0.25% bupivacaine will be injected by aspiration every 2 mL (test dose will be administered with 1 mL saline).